The Fifth Circuit Court of Appeals just slapped the FDA so hard you could hear it in every Planned Parenthood lobby in America. The court ruled that the FDA’s decision to let abortion pills get prescribed over a video call and mailed to your house like an Amazon package was — and try not to faint here — not based on adequate safety science.
Shocking. The agency that wanted to regulate your multivitamins into oblivion gave the abortion pill the express lane through safety review. Who could have possibly predicted that cutting corners on a drug that ends pregnancies might raise a few red flags?
Here’s what happened. Back in 2023, the FDA removed the requirement that women actually see a doctor in person before getting mifepristone — that’s the abortion pill, for those keeping score at home. Instead, the agency said a quick telemedicine call was fine. Chat with a doctor on your laptop for ten minutes, and the pills show up at your door. No in-person exam. No ultrasound. No checking for ectopic pregnancies that could literally kill you. Just click, chat, and swallow.
Louisiana said absolutely not, sued the FDA, and took their case to the Fifth Circuit. And the court agreed — granting an emergency stay that blocks the telemedicine-by-mail scheme and reinstates the requirement that women actually visit a doctor before taking a drug that carries real medical risks.
But here’s the part that should make every American sit up straight. The FDA — the same FDA that tells you which medications are safe, that approves what goes into your body, that we’re all supposed to trust with our lives — admitted in court that its own safety study supporting remote prescribing “was inadequate.”
Read that again. The FDA admitted its safety data was garbage. And then — AND THEN — it argued that the court should let the telemedicine rule stay in place anyway while they “continued their review.”
“Yeah, Your Honor, we know our homework was wrong, but can we keep getting credit for it while we redo it?” Unbelievable.
This is the regulatory state in a nutshell. When the left wants something — abortion access, in this case — the FDA rolls out the red carpet. Safety protocols? Streamlined. In-person requirements? Eliminated. Normal drug approval scrutiny? What scrutiny? But try getting a new vitamin supplement or an off-label prescription for something that actually helps people and suddenly the FDA turns into the strictest hall monitor in the building.
The double standard has always been the point. The FDA isn’t a neutral scientific body. It’s a political institution that wears a lab coat. And this week, a federal court finally said so.
Louisiana’s attorneys laid it out cleanly. The 2023 rule was enabling illegal abortions in states that had restricted the procedure. Women were getting pills mailed across state lines with zero medical oversight, and when complications happened — and they DID happen — the costs landed on state Medicaid programs. Taxpayers were footing the bill for the FDA’s political favor.
The court found Louisiana demonstrated irreparable harm and a strong likelihood of winning on the merits. Translation: the FDA is probably going to lose this one for good.
Legal analysts are already predicting the Supreme Court will take this up fast. And given the current Court’s track record of telling federal agencies to stay in their lane — see Chevron, see the EPA, see basically every major admin law case of the last three years — the FDA should probably start updating its legal defense budget.
This isn’t just about the abortion pill, by the way. This is about whether unelected bureaucrats at federal agencies get to rewrite their own safety rules whenever the political winds shift. The FDA decided that in-person doctor visits were unnecessary — not because the science changed, but because the politics demanded it. A court just said that’s not how this works.
For years, we’ve been told to “follow the science.” Remember that? They put it on bumper stickers. They said it with straight faces on cable news while shutting down churches and keeping liquor stores open. “Follow the science” was always code for “follow our politics and don’t ask questions.”
Well, a federal court just asked questions. And the FDA didn’t have answers.
The pills are still available — nobody banned mifepristone. But now, if you want one, you have to actually see a doctor. In person. Like a normal medical patient getting a normal medical prescription. The horror, right?
The left is going to scream that this is about controlling women’s bodies. It’s not. It’s about the FDA admitting its own safety review was inadequate and a court saying, “Then fix it before you keep handing out pills through the mail.” That’s not extremism. That’s common sense wearing a judge’s robe.
